FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Suzanne Egyhazi

Research Profile

Chemicals & Drugs

Physiology

Mutation

Disorders

Genes & Molecular Sequences

Concepts & Ideas

Cohort Studies

Phenomena

Amination

Co-author Network

Publications

TOP 3
Braslav Jovanovic; Doris Kröckel; Diana Linden; Bo Nilsson; Suzanne Egyhazi; Johan Hansson
Lack of cytoplasmic ERK activation is an independent adverse prognostic factor in primary cutaneous melanoma.
Keiran Smalley; Mercedes Lioni; Maurizia Dalla Palma; Min Xiao; Brijal Desai; Suzanne Egyhazi; Johan Hansson; Hong Wu; Alastair J King; Patricia Van Belle; David E Elder; Keith T Flaherty; Meenhard Herlyn; Katherine L Nathanson
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
Anton Platz; Suzanne Egyhazi; Ulrik Ringborg; Johan Hansson
Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Suzanne Egyhazi (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2008: Braslav Jovanovic; Doris Kröckel; Diana Linden; Bo Nilsson; Suzanne Egyhazi; Johan Hansson
Lack of cytoplasmic ERK activation is an independent adverse prognostic factor in primary cutaneous melanoma.
The Journal of investigative dermatology 2008;128(11):2696-704.
2008: Keiran Smalley; Mercedes Lioni; Maurizia Dalla Palma; Min Xiao; Brijal Desai; Suzanne Egyhazi; Johan Hansson; Hong Wu; Alastair J King; Patricia Van Belle; David E Elder; Keith T Flaherty; Meenhard Herlyn; Katherine L Nathanson
Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E-mutated melanomas.
Molecular cancer therapeutics 2008;7(9):2876-83.
2008: Anton Platz; Suzanne Egyhazi; Ulrik Ringborg; Johan Hansson
Human cutaneous melanoma; a review of NRAS and BRAF mutation frequencies in relation to histogenetic subclass and body site.
Molecular oncology 2008;1(4):395-405.
2007: Shahab Akhoondi; Dahui Sun; Natalie von der Lehr; Sophia Apostolidou; Kathleen Klotz; Alena Maljukova; Diana Cepeda; Heidi Fiegl; Dimitra Dafou; Dimitra Dofou; Christian Marth; Elisabeth Mueller-Holzner; Martin Corcoran; Markus Dagnell; Sepideh Zabihi Nejad; Babak Noori Nayer; Mohammad Reza Zali; Johan Hansson; Suzanne Egyhazi; Fredrik Petersson; Per Sangfelt; Hans Nordgren; Dan Grander; Steven I Reed; Martin Widschwendter; Olle Sangfelt; Charles H. Spruck
FBXW7/hCDC4 is a general tumor suppressor in human cancer.
Cancer research 2007;67(19):9006-12.
2005: Max Käller; Rainer Tuominen; Afshin Ahmadian; Veronica Magnusson; Suzanne Egyhazi; Johan Hansson; Joakim Lundeberg
Detection of MC1R polymorphisms with protease-mediated allele-specific extension as an alternative to direct sequencing.
Clinical chemistry 2005;51(12):2388-91.
2005: Yudi Pawitan; Judith Bjöhle; Lukas Amler; Anna-Lena Borg; Suzanne Egyhazi; Per Hall; Xia Han; Lars Holmberg; Fei Huang; Sigrid Klaar; Edison Liu; Lance Miller; Hans Nordgren; Alexander Ploner; Kerstin Sandelin; Peter M Shaw; Johanna Smeds; Lambert Skoog; Sara Wedrén; Jonas Bergh
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts.
Breast cancer research : BCR 2005;7(6):R953-64.
1997: Y Liu; Suzanne Egyhazi; Johan Hansson; S V Bhide; P S Kulkarni; Roland C Grafström
O6-methylguanine-DNA methyltransferase activity in human buccal mucosal tissue and cell cultures. Complex mixtures related to habitual use of tobacco and betel quid inhibit the activity in vitro.
Carcinogenesis 1997;18(10):1889-95.